510(k) Report

510(k) · Cleared

Cleared

Vascutek Twillweave Vascular Graft

K964959510(k) TraditionalCleared Mar 10, 199789-day reviewClass II21 CFR 870.3450

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Vascutek, Ltd. · DSY Prosthesis, Vascular Graft, Of 6mm And Greater Diameter

Cleared on Mar 10, 1997 as substantially equivalent to K952293 (Vascutek, Ltd., 1995) after an 89-day review. Its family tree reaches back 1 generation to 1995.

Decided
Mar 10, 1997
Review
89 days
Class
Class II
Product code
DSY
Recalls
None
Predicates
1

Its longest line of descent runs back 1 generation to K952293 (1995). No later device cites it as a predicate yet.

K952293 · Vascutek Gelweave Vascular Graft · Vascutek, Ltd. · 199519961998
K952293 · Vascutek Gelweave Vascular Graft · Vascutek, Ltd. · 19950
  1. Root · 1 generation backK952293 Vascutek Gelweave Vascular GraftVascutek, Ltd. · 1995
  2. This deviceK964959 Vascutek Twillweave Vascular GraftVascutek, Ltd. · 1997
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−1K952293Vascutek Gelweave Vascular GraftVascutek, Ltd.1995—
0 (this device)K964959Vascutek Twillweave Vascular GraftVascutek, Ltd.1997—
FIG. 1 — Lineage of K964959, 1995–1997Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in DSY? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new DSY device

  1. #1 K252445 Fusion Bioline Vascular Graftscore 12.4 · 5 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K952293Vascutek Gelweave Vascular Graft
Summary page 1
…lent in intended use, base material (polyester), and function to the Vascutek Gelweave™ vascular graft which received marketing clearance on December 19, 1995 510(k) via K952293. Common name of the device: Prosthesis, Vascular Graft Trade or Proprietary name: Vascutek Twillweave™ vascular graft Submitter…
Vascutek, Ltd.1995—

Also cleared against K952293: 3 other devices →

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • Its one ancestor has no recall.
  • 3 other devices also cite its predicate K952293.

How does its category compare?

All DSY devices

DSY Prosthesis, Vascular Graft, Of 6mm And Greater Diameter: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · DSY

2in 2025

2007: 12008: 12009: 52010: 42011: 12012: 42013: 52014: 22015: 12016: 12017: 32018: 12019: 12020: 12021: 22022: 22023: 22024: 52025: 22026 (partial year): 1
2007high 5 (2009) · low 1 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · DSY

160in 2024

2009: 73 days median2010: 55 days median2012: 30 days median2013: 69 days median2017: 269 days median2024: 160 days median
2007high 269 (2017) · low 30 (2012)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · DSY

1in 2025

2009: 22010: 52013: 12016: 22025: 12026 (partial year): 1
2007high 5 (2010) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · DSY

151in 2025

2007: 1202008: 1642009: 1932010: 1872011: 1652012: 1772013: 2072014: 3522015: 4602016: 2172017: 1932018: 2002019: 2322020: 1692021: 1682022: 1552023: 1492024: 1532025: 151
2007high 460 (2015) · low 120 (2007)2025

MAUDE reports naming product code DSY, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20071—0120
20081—0164
20095732193
20104555187
20111—0165
20124300177
20135691207
20142—0352
20151—0460
20161—2217
201732690193
20181—0200
20191—0232
20201—0169
20212—0168
20222—0155
20232—0149
202451600153
20252—1151
20261—1—

What is it indicated for?

The Twillweave™ Vascular Graft is indicated for repair or replacement of damaged and diseased vessels of the arterial system in cases of aneurysmal or occlusive disease.

Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.

Cite this page

510(k) Report. “K964959: Vascutek Twillweave Vascular Graft.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 4, 2026. https://510kreport.com/device/K964959

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026